Industries > Pharma > Global Macular Degeneration (AMD) and Other Retinal Diseases Drugs Industry and Market 2019-2029

Global Macular Degeneration (AMD) and Other Retinal Diseases Drugs Industry and Market 2019-2029

Wet AMD, Dry AMD, Diabetic Retinopathy, Lucentis, Eylea, Avastin, Visudyne

PUBLISHED: 31 July 2019
PAGES: 170
PRODUCT CODE: PHA0460
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1

The global macular degeneration and other retinal diseases market is estimated at $14.85bn in 2018 and is expected to grow at a CAGR of 6.7% during the forecast period.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 176-page report you will receive 110 charts– all unavailable elsewhere.

The 176-page report provides clear detailed insight into the macular degeneration (AMD) and other reginal diseases drugs market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global AMD and Other Retinal Diseases Market forecasts from 2019-2029

• Revenue forecasts for Global AMD and Other Retinal Diseases Drugs Market by Disease Segment from 2019-2029:
• Wet AMD
• Dry AMD
• Diabetic Retinopathy
• Other Retinal Diseases

• Revenue forecasts for Global AMD and Other Retinal Diseases Drugs Market by Product from 2019-2029:
• Lucentis
• Eylea
• Avastin
• Visudyne
• Others

Drugs Banner

• Revenue forecasts for the Global AMD and Other Retinal Diseases Drugs Market by Region from 2019-2029:
• U.S.
• Japan
• China
• Germany
• France
• UK
• Italy
• Spain
• Brazil
• Russia
• India
• Rest of the World

Global Macular Degeneration (AMD) and Other Retinal Diseases Drugs Industry and Market 2019-2029

• Discussion and profiles of the below selected leading companies:
• Acucela, Inc.
• Allergan Plc
• Bayer AG
• F. Hoffman-La Roche, Ltd.
• GlaxoSmithKline Pharmaceuticals, Ltd.
• IVERIC bio, Inc.
• Novartis AG
• Pfizer, Inc.
• Regeneron Pharmaceuticals
• Valent Pharmaceuticals International, Plc

• Analysis of the Drivers, Restraints, Opportunities and Threats of the global AMD and other retinal diseases market

• The report also includes a SWOT and STEP analysis of the global AMD and other retinal diseases market

• Discussion on the pipeline for Wet AMD. Dry AMD and Diabetic Retinopathy

• Key questions answered by this report:
• How is the retinal diseases market evolving and what are the market prospects from 2018?
• What forces stimulate and restrain that market?
• What are the sales figures for retinal diseases?
• How will revenues of retinal diseases segments grow over the forecast period, 2019 to 2029?
• How will individual product sales develop to 2029?
• Which R&D pipeline products are likely to dominate the market in the next ten years, and what are their sales potentials?
• Which submarkets and national markets form the main drivers of the overall world market to 2029?
• How will social, technological, economic and political forces influence regional markets and world-level submarkets?
• How will market shares of top countries change by 2029 – with their revenues – and which regions will lead the market in 2029?
• Who are the leading companies and what are their prospects over the forecasted period?

Visiongain’s study is intended for anyone requiring commercial analyses for the macular degeneration (AMD) and other reginal diseases drugs market. You find data, trends and predictions.

Visiongain is a trading partner with the US Federal Government
CCR Ref number KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Global Macular Degeneration (AMD) and Other Retinal Diseases Drugs Industry and Market 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Global Macular Degeneration (AMD) and Other Retinal Diseases Drugs Industry and Market 2019-2029


Latest Pharma news

Visiongain Publishes Clinical Trial Supplies Market Report 2021-2031

Deviating from protocols raises the danger of missing or delaying data collection from current investigations. This highlights the growing importance of digital medicine, which is being aided by advancements in cloud, mobile, and IoT technology.

11 October 2021

READ

Visiongain Publishes Drug Discovery Informatics Market Report 2021-2031

High performance HPC and supercomputing technology have evolved substantially in China in the last decades, leading to extraordinary accomplishments. HPC-based and combined pharmaceutical chemical and computational biology computational discovery and design has become a significant technique in drug research and development and is sponsored financially by the Chinese government.

07 October 2021

READ

Visiongain Publishes Pharma Wholesale and Distribution Market Report 2021-2031

Many health-care organizations are seeing organic growth at levels that their supply networks were never designed to handle. Others are frantically attempting to integrate diverse technology and procedures as part of a consolidation effort.

06 October 2021

READ

Visiongain Publishes Meningococcal Vaccines Market Report 2021-2031

Rise in prevalence of meningitis, increasing initiatives by government and regulatory authorities coupled strong funding support from non-profit organizations is expected to drive the global meningococcal vaccines market

05 October 2021

READ

Categories